ANGI vs GDEV

ANGI's Piotroski F-Score of 4/9 indicates weak financial health, falling short of the 7-9 threshold for strong stability. The absence of an Altman Z-Score raises concern over potential distress risk, especially given the company's declining revenue and earnings trends. While the Graham Number ($22.13) suggests undervaluation, the intrinsic value estimate ($6.58) and current price ($7.39) imply a modest premium, unsupported by consistent profitability or growth. The stock has underperformed dramatically over the past 5 years, with a 95.6% decline, and recent earnings misses have been severe, averaging a -32.28% surprise over the last four quarters. These factors collectively point to a fundamentally weak and deteriorating business.

GDEV presents a contradictory profile characterized by deep valuation discounts and significant balance sheet distress. While the Piotroski F-Score of 6/9 indicates stable operational health and the P/E of 4.48 suggests extreme undervaluation relative to an intrinsic value of $28.0, the negative Price/Book ratio (-3.38) reveals negative shareholders' equity. Liquidity is a primary concern with a current ratio of 0.67, and the negative revenue growth (-7.90%) offsets the impressive YoY EPS recovery. The stock is a speculative value play where operational profitability is fighting against a compromised capital structure.